Congressional Democrats heralded a new Government Accountability Office report (PDF) as proof that the Patient Protection and Affordable Care Act's discount prescription drug program is working as planned.
Starting in January 2011, the law stipulated that drugmakers that want their products covered under Medicare Part D must participate in the drug discount program. Under this provision, the drug manufacturers must provide a 50% discount on the price that Part D plan sponsors negotiate for brand-name drugs when beneficiaries reach the so-called doughnut hole—the gap between the initial and catastrophic coverage periods where Medicare helps pay the costs.
Read the full story: http://tinyurl.com/8n432mf
Source: Modern Healthcare
Chronic Spontaneous Urticaria Linked to Higher Patient Burden, Worse Quality of Life
August 7th 2025Chronic spontaneous urticaria places a heavier burden on patients than atopic dermatitis and psoriasis, leading to a worse quality of life and higher health care costs, underscoring the critical need for better treatments.
Read More
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Use of GLP-1 RAs Associated With Increased Risk of NAION in Patients With Diabetes
August 6th 2025Results confirm previous findings that nonarteritic anterior ischemic optic neuropathy (NAION) was more likely in those who used semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA).
Read More